"10.1371_journal.pone.0054521","plos one","2013-01-18T00:00:00Z","Juerg Barben; Marie-Pierre F Strippoli; Daniel Trachsel; Barbara Schiller; Juerg Hammer; Claudia E Kuehni","Department of Paediatric Pulmonology & Allergology, Children’s Hospital, St. Gallen, Switzerland; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; Department of Pulmonology and Intensive Care, University Children’s Hospital Basel, Basel, Switzerland","Editing and review of the manuscript: JB MPS DT BS JH CEK. Conceived and designed the experiments: JB DT JH CEK. Performed the experiments: JB DT BS JH. Analyzed the data: MPS CEK. Contributed reagents/materials/analysis tools: JB. Wrote the paper: JB MPS CEK.","The authors would like to declare commercial funder AstraZeneca (Switzerland) as a competing interest. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Juerg Barben","JB",6,TRUE,4,4,2,3,TRUE,FALSE,FALSE,0,NA,FALSE
